SCHEMBL7871341

SCHEMBL7871341

COCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)C3CCCCC3)cc2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
TSHR P16473 2/20 0.46
CYP2C19 P33261 2/20 0.46
BLM P54132 2/20 0.46
HTR1A P08908 1/20 0.46
NFKB1 P19838 1/20 0.46
CNR1 P21554 1/20 0.46
ADRA1A P35348 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
NPC1 O15118 3/20 0.43
ALDH1A1 P00352 3/20 0.40
ABCC3 O15438 1/20 0.40
ABCC4 O15439 1/20 0.40
ABCC9 O60706 1/20 0.40
ABCB11 O95342 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870460 0.93 MAPT (0.44) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL7870549 0.92 MAPT (0.47) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL7868035 0.91 MAPT (0.43) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL7874653 0.91 KMT2A (0.41) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL9018314 0.90 MAPT (0.49) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL7869495 0.89 LMNA (0.45) LMNATSHRSMN1; SMN2KMT2AMEN1
SCHEMBL7867832 0.89 EPHX2 (0.43) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL8869656 0.88 MAPT (0.56) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL7871597 0.86 LMNA (0.44) MAPTLMNACYP3A4CYP2C9TSHR
SCHEMBL7870515 0.86 POLB (0.44) LMNASMN1; SMN2KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed